Hjem › Klarcellet metastatisk nyrecellekarcinom › California
Kliniske studier for Klarcellet metastatisk nyrecellekarcinom i California
9 studier for Klarcellet metastatisk nyrecellekarcinom søker deltakere på steder i California.
Byer i California
Offisiell studietekst (engelsk)
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
- NEO-811 Los Angeles Site, Duarte
- NEO-811 San Diego Site, San Diego
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07300241Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Research Site, Duarte
- Research Site, Irvine
- Research Site, La Jolla
- og 4 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07011719Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
- City of Hope Investigational Drug Services (IDS), Duarte
- UC San Diego Medical Center - Encinitas, Encinitas
- og 13 flere
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07227415Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
- City of Hope National Medical Center, Duarte
- Chao Family Comprehensive Cancer Center, Orange
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT05361720Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
- University of California, San Francisco, San Francisco
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT07043608Imaging of Solid Tumors Using 18F-TRX
- University of California, San Francisco, San Francisco
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. jul. 2026 · NCT06942104Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer
- City of Hope Medical Center, Duarte
- City of Hope Medical Center, Irvine
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 16. jul. 2026 · NCT07128680Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- PCR Oncology, Arroyo Grande
- Sutter Auburn Faith Hospital, Auburn
- Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn
- og 34 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2025 · NCT04510597CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
- City of Hope Medical Center, Duarte
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 30. mai 2024 · NCT06399419Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.